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Abstract
Background: The direction of cytokine secretion from polarized cells determines the cytokine's
cellular targets. Leukemia inhibitory factor (LIF) belongs to the interleukin-6 (IL-6) family of
cytokines and signals through LIFR/gp130. Three factors which may regulate the direction of LIF
secretion were studied: the site of stimulation, signal peptides, and expression levels. Stimulation
with IL-1β is known to promote IL-6 secretion from the stimulated membrane (apical or
basolateral) in the human intestinal epithelial cell line Caco-2. Since LIF is related to IL-6, LIF
secretion was also tested in Caco-2 following IL-1β stimulation. Signal peptides may influence the
trafficking of LIF. Two isoforms of murine LIF, LIF-M and LIF-D, encode different signal peptides
which have been associated with different locations of the mature protein in fibroblasts. To
determine the effect of the signal peptides on LIF secretion, secretion levels were compared in
Madin-Darby canine kidney (MDCK) clones which expressed murine LIF-M or LIF-D or human LIF
under the control of an inducible promoter. Low and high levels of LIF expression were also
compared since saturation of the apical or basolateral route would reveal specific transporters for
LIF.
Results: When Caco-2 was grown on permeable supports, LIF was secreted constitutively with
around 40% secreted into the apical chamber. Stimulation with IL-1β increased LIF production.
After treating the apical surface with IL-1β, the percentage secreted apically remained similar to
the untreated, whereas, when the cells were stimulated at the basolateral surface only 20% was
secreted apically. In MDCK cells, an endogenous LIF-like protein was detected entirely in the apical
compartment. The two mLIF isoforms showed no difference in their secretion patterns in MDCK.
Interestingly, about 70% of murine and human LIF was secreted apically from MDCK over a 400-
fold range of expression levels within clones and a 200,000-fold range across clones.
Conclusion: The site of stimulation affected the polarity of LIF secretion, while, signal peptides
and expression levels did not. Exogenous LIF is transported in MDCK without readily saturated
steps.
Background
Most cells secrete a variety of cytokines, either continu-
ously or in response to stimulation. The spatial regulation
of cytokine secretion is important since it determines
which neighbouring cells respond, but little is known
about how cytokine secretion in the constitutive pathway
is regulated. With their prominent apical and basolateral
domains, epithelial cells have been studied extensively for
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their ability to sort membrane proteins to specific
domains. Sorting depends on hierarchical signals and
occurs in multiple stages of the secretory pathway [as
reviewed in [1-3]]. Lipid raft-associated and independent
pathways have been identified for transport from the
trans-Golgi to the apical membrane [4]. Less is known
about the sorting of secreted proteins. N-glycans and O-
glycans as well as proteinaceous patches have been pro-
posed as sorting signals. Lectins may cooperate with lipid
rafts in the transport routes [5].
LIF is a secreted, glycosylated cytokine, of the IL-6 family,
that exhibits pleiotropic activities in a wide range of tis-
sues and cell types. LIF is produced by epithelial cells dur-
ing development and during infection and inflammation,
including in the intestine [6], the uterus [7] the lung [8],
and the kidney [9].
When cultured on permeable supports, Caco-2 cells dis-
play the features of differentiated small intestinal entero-
cytes, forming polarized monolayers with tight junctions.
We chose to characterise LIF secretion by Caco-2, since
Moon et al. [10] made an intriguing observation about IL-
6 secretion in these cells. They reported that IL-6 secretion
was higher from the membrane domain (apical or basola-
teral) that was stimulated with IL-1β than from the non-
stimulated domain, suggesting that secretion could be
locally facilitated by a pro-inflammatory stimulus.
Whether or not LIF is secreted in a similar way is interest-
ing since LIF and IL-6 are related cytokines and may be co-
regulated.
We also studied LIF secretion in MDCK, a renal cell line
which displays characteristics of distal tubule cells and
collecting duct cells [11]. MDCK were selected since the
cell line is well suited to exogenous expression. Murine
LIF (mLIF) and human LIF (hLIF) are easily distinguished
from endogenous canine LIF in ELISAs. Inducible expres-
sion systems based on tetracycline-regulated promoters
are available for MDCK which allow the effects of differ-
ent expression levels on secretion to be measured. Few
studies have systematically examined the effects of varying
expression levels. Marmorstein et al. [12] conducted a
study of vascular endothelial growth factor (VEGF165) and
transforming growth factor β1(TGF-β1) secretion at differ-
ent expression levels in a retinal pigment epithelial cell
line (RPE-J) by varying the amount of adenovirus used to
transfect the cells. Their results indicated that these
cytokines were secreted in apical pathways that were read-
ily saturated, suggesting specific transporters. For exam-
ple, VEGF dropped dramatically from 100% apical
secretion to 30% apical with increased expression levels.
We tested whether this result could be generalized to mLIF
and hLIF in MDCK.
Exogenous expression also facilitated study of the contri-
bution of LIF signal peptides to LIF trafficking. Two
secreted isoforms of LIF are derived from the murine LIF
gene. The isoforms, corresponding to transcripts LIF-D
and LIF-M, encode different signal peptides, which in at
least some fibroblasts appeared to affect the localization
of LIF protein. After cleavage of the signal peptides, the
mature murine proteins had the same polypeptide
sequence but the LIF-D protein was secreted and freely dif-
fusible; whereas the LIF-M was secreted but remained
associated with the extracellular matrix [ECM;  [13]]. LIF-
D and LIF-M transcripts are also produced from the hLIF
gene [14,15]; however, differences in localization of the
products have not been reported. If, as in fibroblasts, LIF-
M was associated with the ECM in epithelial cells, LIF-M
secretion might be preferentially directed toward the
basolateral membrane, where the ECM is present. To test
this hypothesis, LIF-M and LIF-D were exogenously
expressed in MDCK.
Our results suggest that exogenous LIF is predominantly
secreted in an apical direction in MDCK, regardless of sig-
nal peptide or expression level, indicating a lack of specific
transporters for LIF.
Results
Caco-2 secreted LIF
The polarized secretion of a number of cytokines includ-
ing IL-6 has been described in Caco-2 cells [10]. Secretion
of LIF by Caco-2 has not been previously reported. Caco-
2 cells were grown as a confluent monolayer in tissue cul-
ture flasks for two weeks to allow them to fully differenti-
ate. Conditioned media was then collected over a 48 hour
period and assayed for LIF-like activity using a BA/F3-
mLIFR-mgp130 assay (hLIF will activate mLIFR/mgp130).
The conditioned media displayed a LIF-like activity,
which was detectable over background in up to a 1:16
dilution and did not support BA/F3 parental cells (lacking
mLIFR/mgp130). A polyclonal antibody raised against
eukaryotic human LIF inhibited the proliferative
responses by 75% (data not shown). The neutralization
by anti-LIF antibodies demonstrates that a large propor-
tion if not all of the activity in the conditioned media is
due to hLIF itself and not to other LIFR-dependent lig-
ands.
An hLIF ELISA, which uses antibodies raised against glyc-
osylated hLIF, detected 32 pg/ml hLIF in the Caco-2 con-
ditioned media. This concentration is similar to what was
predicted from the BA/F3-mLIFR/mgp130 assays. The
ELISA result demonstrates that Caco-2 constitutively
secrete small amounts of LIF.BMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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Caco-2 preferentially secreted LIF from the basolateral 
membrane
To determine the polarity of LIF secretion, Caco-2 cells
were grown on permeable filters. The formation of a
sealed monolayer after 14 days was confirmed by meas-
urements of the transepithelial electrical resistance
(TEER), which, in unstimulated cells reached approxi-
mately, 1,800 Ω.cm2. Following conditioning for 24
hours, the media from the apical and basal chambers was
analyzed by ELISA. As the volumes recovered from the
apical and basolateral chambers differed (0.9 ml vs 1.4
ml), amounts rather than concentrations are reported.
Unstimulated Caco-2 cells produced on average 46 pg
total LIF protein of which 41% was secreted into the apical
chamber (Fig. 1a and 1b). This differential accumulation
of LIF is likely to represent genuine differences in secre-
tion since transport of LIF across the monolayer was very
limited (data not shown).
Secretion of LIF and IL-6 by Caco-2 was influenced by the 
site of stimulation with IL-1β
Apical or basal treatment alone with IL-1β resulted in an
increase in the total amount of LIF secreted, but the
increase was not statistically significant. Simultaneous
treatment of both sides (dual stimulation) resulted in a
significant 7-fold increase relative to unstimulated cells
(Fig. 1a). Differences between apical and basolateral stim-
ulation were apparent when considering the polarity of
secretion. With apical stimulation, 42% of the LIF was
secreted apically, whereas with basolateral stimulation
only 20% of the LIF was secreted apically, demonstrating
that the site of stimulation is important in determining
the direction of secretion (Fig 1b). Dual stimulation
yielded an intermediate percentage secreted apically. The
effect of IL-1β on LIF trafficking is not due to a disruption
of the monolayer integrity since stimulation with IL-1β
Caco-2 regulated the direction of secretion of LIF and IL-6 in response to IL-1β Figure 1
Caco-2 regulated the direction of secretion of LIF and IL-6 in response to IL-1β. Caco-2 were grown on permeable 
supports. a, c) The total amount of LIF and IL-6 secreted into both apical and basal chambers was determined by ELISA 24 
hours after addition of IL-1β (1 ng/ml) into either the apical (A), basal (B) or both chambers (A+B). b, d) The percentage of LIF 
and IL-6 secreted into the apical chamber following treatment. Values represent the mean +/- SEM (n = 3). ND (not detected). 
*p < 0.05 vs. no stimulation; #p < 0.05 apical vs. basolateral stimulation.BMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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did not have a significant effect on monolayer permeabil-
ity (data not shown).
The samples collected for LIF secretion were also assayed
for IL-6 using an IL-6 ELISA. In contrast to LIF, IL-6 secre-
tion was not detected in untreated cells (Fig. 1c). Apical,
basal or dual stimulation with IL-1β all increased IL-6
secretion, but only the basal and dual increases were sig-
nificant, reaching an average of 284 pg with dual stimula-
tion. When stimulated at the apical membrane, 57% of
the IL-6 was secreted into the apical chamber (Fig. 1d). In
contrast, basolateral treatment with IL-1β resulted in only
33% secreted apically. With stimulation of both sides of
the monolayer, an intermediate percentage was secreted
apically. As with LIF, therefore, the polarity of IL-6 secre-
tion was differentially regulated by IL-1β at the apical and
basolateral membranes. The two cytokines show a closely
related but not identical pattern of secretion.
MDCK secreted a LIF-like factor from the apical 
membranes
The availability of tetracycline-responsive systems (Tet
off) for MDCK makes it an attractive cell line for manipu-
lating secretion. Demonstrating that MDCK secreted
endogenous LIF in a polarized manner would suggest that
the cells actively sort LIF. Studying the secretion of endog-
enous LIF in MDCK, however, is problematic since anti-
bodies to canine LIF are not available. In lieu of an ELISA,
conditioned media from unstimulated MDCK was
assayed on BA/F3-mLIFR-mgp130 cells. The media dem-
onstrated a LIF-like activity that was dependent upon LIF-
R/gp130 (data not shown). Since the efficiency with
which this assay detects the canine-LIF-like activity is
unknown, the assay can only measure relative amounts of
LIF-like activity. When monolayers of MDCK were grown
on permeable filters, and conditioned media was col-
lected after 48 hours, all of the LIF-like activity was
detected in the apical compartment (Fig. 2). The apical
activity could be diluted up to at least 8-fold and still stay
within the linear range of the assay. Taking account of the
greater dilution of proteins secreted into the basal com-
partment, if 20% or more of the LIF-like activity was
secreted into the basal compartment, it should have been
detected in the bioassay. Stimulating the MDCK cells with
human IL-1β did not increase the secretion of the LIF-like
activity (data not shown) perhaps because the human
cytokine is a weak agonist for the canine receptor [16].
MDCK mLIF clones secrete LIF primarily from the apical 
membrane
Since the level of expression has been shown to influence
the direction of secretion of growth factors, several stable
MDCK Tet-off LIF cell lines were generated for study using
the PBI-L expression vector. PBI-L contains a bi-direc-
tional promoter, allowing clones to be selected according
to their expression of luciferase and/or LIF. To test the
polarity of secretion at the minimum and maximum lev-
els of LIF expression, clones were grown on permeable
supports and analyzed both in the fully switched on state
(no doxycycline; No Dox) or fully switched off (1 μg/ml
Dox). Both mLIF and hLIF-expressing clones were gener-
ated since differences in their surface-exposed amino acids
might result in differences in protein sorting.
As MDCK cells are responsive to stimulation with hLIF
[17], the effects of mLIF and hLIF on monolayer integrity
were first tested. Eukaryotic mLIF or hLIF (1 ng/ml) was
added to both sides of confluent monolayers and the
effects on TEER were tested after 24 hours. MDCK cells
produced TEERs in the region of 700–850 Ω.cm2 after five
days growth on filters. No significant difference in TEER
was observed following stimulation with either mLIF or
hLIF in comparison to untreated cells. At most small
amounts of LIF were transported across the monolayer.
After adding LIF to the apical or basal side, less than 5%
of the recovered LIF was detected in the opposite cham-
ber.
Four  MDCK-Tet-off mLIF-D clones were analyzed by
growing the clones on permeable supports and then
assaying the mLIF which accumulated in the apical or
basal compartment after 24 hours. Clones 9 and 19
secreted on average 61 and 7 nanograms of mLIF respec-
tively with around 67% of the mLIF secreted apically.
MDCK apically secreted an endogenous LIF-like factor Figure 2
MDCK apically secreted an endogenous LIF-like fac-
tor. MDCK cells were grown on permeable supports for 24 
hours and the conditioned media was collected from the api-
cal and basal chambers. The collected media was then ana-
lyzed for LIF-like activity using the BA/F3 mLIR-mgp130 cell 
assay. Results are expressed as the A570 value of cells assayed 
for proliferation by 3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyl 
tetrazolium bromide (MTT). Values represent the average 
activity present in a dilution series of media collected from an 
individual transwell assayed in triplicate. Two Transwells® are 
shown with one denoted by a square and one by a triangle. A 
single representative experiment is shown of n = 3.BMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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They did not differ significantly in their preference for api-
cal secretion at lower expression levels (< 1 ng) observed
with 1 μg/ml Dox (63% apical; Fig. 3a and 3b). mLIF-D
clone 11 did not produce detectable amounts of mLIF in
the presence of 1 μg/ml Dox but with lower amounts of
Dox (0.5 ng/ml and 1 ng/ml), mLIF was detected (21 pg
and 57 pg respectively). The difference in the percentage
secreted apically between No Dox and 0.5 ng/ml Dox is
statistically significant, but the difference is small (65% vs.
71%). mLIF-D clone 4, without Dox, secreted 62% api-
cally and with Dox, secreted 48% apically. This 14% drop
in the percentage secreted apically was significant but was
small compared to the dramatic changes observed for
VEGF in RPE-J cells (see discussion). Comparing across
expression levels from picograms to nanograms of LIF,
there is no compelling evidence for trafficking machinery
which can be saturated by mLIF-D.
In order to identify any differences in the pattern of secre-
tion between the LIF-D and LIF-M signal peptides, two
MDCK Tet-off-mLIF-M clones were also examined over a
range of expression levels (Fig 3c–f). Without Dox, mLIF-
M clone F produced 11 ng of mLIF (78% in the apical
chamber), whereas with Dox this clone produced signifi-
cantly less mLIF (less than 1 ng) and secreted less of it api-
cally (71%). Without Dox, mLIF-M clone S produced 8 ng
of mLIF (66% in the apical chamber), but with 1 μg/ml
Dox it did not produce detectable amounts of mLIF. The
MDCK Tet-off cells secreted exogenous mLIF-D and mLIF-M predominantly in the apical direction across a range of expres- sion levels Figure 3
MDCK Tet-off cells secreted exogenous mLIF-D and mLIF-M predominantly in the apical direction across a 
range of expression levels. MDCK cells grown on permeable filters were incubated without doxycycline (No Dox) or var-
ying concentrations of doxycycline (Dox) to regulate the expression level of mLIF-D (a, b) or mLIF-M (c-f). After 24 hours, 
conditioned media was collected from the apical and basal chambers and analyzed for mLIF by ELISA. a, c, e) Total amount of 
mLIF secreted. b, d, f) Percentage of mLIF secreted into the apical chamber. Values are expressed as mean +/-SEM (n = 3). ND 
(not detected at 1 μg/ml Dox). *P < 0.05; vs 1 μg/ml Dox. #P < 0.05; vs. 0.5 ng/ml Dox; ~P < 0.05; vs. 1 ng/ml Dox.BMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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experiments were repeated with less Dox (Fig. 3e and 3f).
In these experiments, clone S secreted without Dox, 31 ng
of mLIF (70% in the apical chamber). With 1 ng/ml Dox,
clone S secreted significantly less mLIF (253 pg), but
secreted a similar percentage apically (74%). Thus of the
two clones one showed a difference in the proportion
secreted apically at different levels of expression and one
did not. Both clones secreted the majority of the mLIF in
the apical direction, which is similar to the pattern seen
with clones expressing mLIF-D. There is no evidence for a
difference between the two signal peptides in directing the
polarity of mLIF secretion.
MDCK hLIF clones also preferentially secrete LIF from the 
apical membrane
Four MDCK Tet-off hLIF-D clones were also tested for
their pattern of secretion (Fig 4). Without Dox, hLIF-D
clone 3 produced over 4 μg of hLIF of which 70% of the
hLIF was secreted apically. With Dox this clone produced
significantly less hLIF (10 ng) but secreted a similar per-
centage apically (69%). hLIF-D clones 30 and 16 behaved
in a similar fashion. Clone 29 produced the least amount
of LIF and showed little if any response to Dox. Without
Dox, it produced 211 pg of hLIF of which 70% was in the
apical chamber, whereas with Dox it produced 220 pg of
which 73% was secreted apically. Of the four clones, only
clone 29 showed a significant difference in apical secre-
tion but this very small difference (3%) occurred in the
absence of a significant change in expression levels of
hLIF. Considering the clones together, over a range of con-
centrations from picograms to micrograms of LIF, the pat-
tern of exogenous hLIF secretion is similar to that of
exogenous mLIF in MDCK cells, with about 70% of the
LIF secreted apically. There is no evidence for saturation of
a sorting step in LIF transport.
Discussion
The expression of pro-inflammatory cytokines and their
receptors by normal (unstimulated) intestinal epithelial
cells points towards a role for these cytokines in the nor-
mal growth and maintenance of the gut epithelium. The
secretion of LIF by unstimulated Caco-2 cells is consistent
with the detection of LIF from human colonic epithelial
cells [6] and the presence of LIF in mRNA obtained from
murine intestinal tissue [18]. Guimbaud et al [19]
reported that Caco-2 cells did not make LIF perhaps
because they used a less sensitive ELISA. Whilst the
human colonic epithelium has been reported to lack LIFR
expression, pericryptal fibroblasts express the receptor,
suggesting an interaction of LIF produced by colonic epi-
thelial cells with pericryptal fibroblasts [6]. LIF levels are
increased in inflammation, as demonstrated by high lev-
els of LIF in patients with ulcerative colitis [19]. In con-
trast to LIF, we did not observe constitutive secretion of IL-
6 from Caco-2. This may reflect different physiological
roles for LIF and IL-6 in the normal intestinal epithelium.
It is striking that the site of LIF and IL-6 secretion is influ-
enced by the site of stimulation. Such preferential secre-
tion displays a variety of features. It is observed with some
cytokines and acute phase proteins but not all secreted
proteins [10,20], with only some inducers [21], and in a
variety of polarized cell types [21-24]. The mechanisms
which underlie preferential secretion at the site of stimu-
lation have not been defined and merit future study.
MDCK Tet-off cells secreted exogenous hLIF-D predomi- nantly in the apical direction across a range of expression lev- els Figure 4
MDCK Tet-off cells secreted exogenous hLIF-D pre-
dominantly in the apical direction across a range of 
expression levels. MDCK cells grown on permeable filters 
were incubated without doxycycline (No Dox) or with 1 μg/
ml of doxycycline (Dox) to regulate the expression of hLIF-
D. After 24 hours, conditioned media was collected from the 
apical and basal chambers and assayed for hLIF by ELISA. a) 
Total amount of hLIF secreted. b) Percentage of hLIF 
secreted into the apical chamber. Values are expressed as 
mean +/- SEM (n = 3). *P < 0.05 vs.1 μg/ml Dox.BMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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Enhanced secretion at the site of stimulation could result
from a global response such as an increase in the amount
of membrane incorporated into the stimulated mem-
brane or a change in membrane composition. If the mech-
anisms are global, however, there must remain transport
routes which are not affected by these changes. For exam-
ple, Moon et al. demonstrated in Caco-2 that although IL-
6 displayed a marked preference for secretion through the
membrane stimulated by IL-1β, the secretion of comple-
ment component C3 displayed strong basolateral secre-
tion regardless of the membrane stimulated [10].
Conditioned media from MDCK cells demonstrated LIF-
like activity in BA/F3 mLIFR-mgp130. LIF expression by
MDCK would not be surprising since collecting duct cells
are known in rat to express LIFR and LIF. Following
ischemia-reperfusion injury LIF is expressed more widely
by the epithelial cells of the kidney, where it may partici-
pate in regeneration by stimulating the proliferation of
epithelial cells [25,26]. LIFR is expressed at both the apical
and basolateral membranes of MDCK [17]. The apparent
selectivity for apical secretion of a LIF-like activity
observed here may reflect paracrine signalling between
epithelial cells and is broadly consistent with the apical
secretion observed in the exogenous LIF-expressing
clones. A sensitive ELISA for canine LIF is required for a
more definitive comparison between endogenous and
exogenous expression.
We generated cell clones from MDCK Tet-off cells in
which LIF expression was regulated by a tetracycline-
inducible promoter. The clones demonstrated a wide
range of LIF expression levels when the promoters were
induced or repressed. Exogenous mLIF was mostly
secreted in an apical direction irrespective of whether the
signal peptide was from LIF-D or LIF-M. This suggests that
the LIF-M signal peptide does not direct the secretion of
LIF basolaterally toward the ECM in MDCK. We have not
measured the binding capacity of the ECM for LIF in
MDCK cells. If the binding capacity is similar to that
observed in the osteosarcoma cell line UMR-106 [27],
however, it would be easily saturated when LIF is highly
expressed in the absence of doxycycline and is unlikely to
have affected the measurement of polarity. Cell-type dif-
ferences may be important in the recognition of sorting
signals. When proteins that are polarized in epithelial
cells are expressed in fibroblasts, they display specific
secretion routes [28,29], however, it is not known if routes
used by endogenous proteins in fibroblasts are present in
epithelial cells. LIF may also require a specific "sorting
escort" as has been observed for components of secretory
granules [30].
Interestingly, the level of LIF expression did not influence
the proportion of LIF secreted apically and basolaterally.
The high levels of LIF produced were comparable to those
observed with VEGF when its expression level was manip-
ulated in RPE-J cells [12], but there was no evidence in
MDCK of a shift in LIF polarity with increasing expression
comparable to the shift observed for VEGF (100% to 30%
apical). This failure to observe saturation may reflect a
lack of specific sorting receptors for LIF.
The polarity observed with exogenous mLIF and hLIF
(70% apical) in MDCK may simply reflect the total vol-
ume of vesicles delivered to the apical and basolateral sur-
faces. This hypothesis is attractive since passive
incorporation of LIF into vesicles would account for the
lack of saturation. To our knowledge total vesicular traffic
has not been measured in MDCK so it is not known what
percentage secreted apically would be consistent with pas-
sive transport. Comparisons with other four-helical
cytokines, however, suggest that intrinsic features of LIF
are likely to play a role even in passive transport. Rat
growth hormone which is unglycosylated displayed only
35–40% secreted apically when expressed exogenously in
MDCK [31,32], indicating differential sorting of LIF and
growth hormone. LIF more closely resembles erythropoi-
etin in its secretion pattern. Wild-type erythropoietin dis-
played predominantly apical secretion when exogenously
expressed in MDCK. The percentage apical secretion
dropped to about 50% after the removal of one of the N-
glycosylation sites [33], suggesting that either the N-glyc-
osylation serves as a sorting signal or it is required for the
conformation of a proteinaceous signal. Further experi-
ments could reveal if the glycosylation of LIF was similarly
required for apical secretion. One way in which the glyco-
sylation/conformation of LIF could be important is if it
mediates a preferential affinity for the lipids that compose
apical vesicles or tubules. Constitutive secretory proteins
have been shown to be associated with the lumenal face
of membranes in the secretory pathway [34]. If LIF can
directly interact with lipid domains, it may explain why
saturation was not detected for LIF. The high expression
levels achieved with exogenous LIF will make experiments
with confocal microscopy and detergent solubilization
feasible.
The apical secretion of exogenous LIF and an endogenous
LIF-like activity in MDCK contrasts with the basolateral
preference seen in Caco-2. LIF is not unusual in this
regard. Differences in secretion patterns of transmem-
brane proteins between these two cell lines have been
reported and attributed to differences in the recognition
of basolateral trafficking signals [35]. We haven't deter-
mined whether the preferential secretion of LIF at the site
of stimulation is unique to Caco-2 or shared with MDCK.
Similarly we haven't determined whether the lack of a role
for LIF signal peptides and the absence of saturation are
unique to MDCK. For each of these findings, furtherBMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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experiments are required to test whether they extend to
both epithelial cell lines.
Conclusion
The results presented provide evidence for the secretion of
LIF by intestinal epithelial cells and a LIF-like activity from
kidney epithelial cells. Interesting questions have
emerged as to how the site of stimulation is able to influ-
ence the pattern of protein secretion and how the secre-
tion of exogenous LIF is directed to the apical and
basolateral poles in the apparent absence of specific pro-
tein sorters. More mechanistic approaches are now
required to pursue these questions.
Methods
Cell culture
Caco-2 cells were maintained in DMEM, high glucose,
with L-glutamine (Gibco), 20% FCS (Labtech), 1% MEM
(Gibco), 100 U/ml penicillin, and 100 μg/ml streptomy-
cin (Gibco). BA/F3 mLIR-mgp130 cells were maintained
in RPMI 1640 (Gibco), supplemented with 10% FCS, 50
U/ml penicillin, 50 μg/ml streptomycin, and recombinant
human LIF (20 ng/ml). Parental BA/F3 cells were main-
tained in RPMI 1640 (Gibco), supplemented with 10%
FCS, 50 U/ml penicillin, 50 μg/ml streptomycin, and 100
pg/ml IL-3 (R & D systems). MDCK Tet-off cells (BD Bio-
sciences) were maintained in DMEM high glucose con-
taining 50 U/ml penicillin, and 50 μg/ml streptomycin
and 1 μg/ml puromycin (Sigma). Polarized secretion
experiments were performed with cells grown on 4.7 cm2,
0.4  μm pore size polycarbonate membrane Transwell®
inserts (Costar). Caco-2 cells were seeded into Transwell®
inserts at a density of 4 × 105 cells/well. Media in each
chamber was replaced every two-three days for fourteen
days, after which time monolayer integrity was demon-
strated by measuring transepithelial resistance (TEER;
described below). For stimulation experiments, monolay-
ers were stimulated with 1 ng/ml IL-1β (R & D systems)
for 24 hours. MDCK cells were seeded into Transwell®
inserts at a density of 106 cells/well. Media in each cham-
ber was replaced every 2–3 days for five days, after which
time monolayer integrity was verified by measuring TEER.
Epithelial monolayer integrity
The TEER of each monolayer was measured with an epi-
thelial voltmeter using 'chopstick electrodes' (EVOM
World Precision Instruments, USA). The mean TEER was
calculated from three different positions. The intrinsic
resistance of the insert (permeable support alone) was
subtracted from the total resistance (cell monolayer and
permeable support) to calculate the resistance of the mon-
olayer. The resistance was corrected for surface area of the
permeable support (4.7 cm2) and the TEER was expressed
as Ohms cm2 (Ω.cm2). TEER was determined before the
start and at the end of each period of collecting condi-
tioned media.
Proliferation assay
Activity of conditioned media was assessed by a cell pro-
liferation assay. BA/F3 mLIR-mgp130 is a pro-B-cell line
that has been stably transfected with cDNA, encoding
both components of the mLIF receptor: mLIFR and
mgp130. The assay was performed as described previously
[36]. Proliferation was measured using 1-(4,5-Dimethyl-
thiazol-2-yl)-3,5-diphenylformazan (MTT; [37]). Neutral-
ization of LIF-like activity was achieved by adding 10 μg/
ml of rabbit anti-hLIF (Chemicon; AB1886) to the assay.
ELISAs
LIF and IL-6 concentrations in cell supernatants were
determined by specific ELISA: hLIF, hIL-6 (Bender
MedSystems), and mLIF (Quantikine ELISA; R & D Sys-
tems). In our experiments, the detection limits for eukary-
otic hLIF and hIL-6 were 10 pg/ml. The Quantikine mLIF
kit detected bacterial mLIF down to 20 pg/ml. The kit also
detected purified glycosylated mLIF that we prepared in
eukaryotic cells.
Construction of LIF expression plasmids
mLIF cDNA encoding the LIF-D signal peptide was iso-
lated from the plasmid pXMT2 mLIF-D [13] using the
enzyme EcoR1. The fragment was subcloned into the plas-
mid PcDNA3.1- (Invitrogen) to create the plasmid
PcDNA3-mLIF-D. Murine LIF cDNA encoding the LIF-M
signal peptide was isolated from the plasmid pXMT2
mLIF-M [13] using EcoR1 and Xho1. The fragment was
subcloned into the plasmid, PcDNA3.1 (-), to create the
plasmid PcDNA3.1-mLIF-M. To ensure a comparable 5'
end to the mLIF clones, hLIF-D cDNA was generated from
a pre-existing PcDNA3.1-hLIF plasmid by PCR. The 5' oli-
gonucleotide was directed to the 5' signal peptide and
included a BamH1 site and the 3' oligonucleotide was
directed to the 3' end of the LIF coding sequence and
included an EcoR1 restriction site. The resulting fragment
was subsequently ligated into PcDNA3.1 to create the
plasmid PcDNA3.1-hLIF-D. cDNAs encoding the mLIF-D,
mLIF-M and hLIF-D signal peptides were isolated from
their respective PCDNA3.1 plasmids using the restriction
enzymes Nhe1 and HindIII and were subsequently ligated
into the plasmid pBI-L (BD Biosciences). All constructs
generated by PCR were verified by automated DNA
sequencing (Functional Genomics, University of Birming-
ham).
Stable expression in MDCK Tet-OFF cells
MDCK Tet-Off cells (BD Biosciences) were transfected
with PBI-L-mLIF-D, PBI-L-mLIF-M, and PBI-L hLIF-D
using calcium phosphate. Stably transfected cells were
selected in media containing 100 ng/ml hygromycin andBMC Cell Biology 2008, 9:53 http://www.biomedcentral.com/1471-2121/9/53
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1 μg/ml doxycycline and cloned using cloning cylinders
(Sigma). Cells expressing exogenous LIF were identified
by luciferase activity transcribed from the bi-directional
promoter of PBI-L and by LIF ELISA.
Data Analysis
Results are presented as mean ± standard error of the
mean (SEM) of three separate experiments in which
duplicate wells were analyzed except where otherwise
specified. For comparing total secretion in the presence
and absence of doxycycline, unpaired t tests were per-
formed. For comparing proportions, the data was first
normalized by taking the arcsine of the square root of the
proportion. When more than two results were compared,
an analysis of variance (ANOVA) followed by the Tukeys
test was performed.
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